Related Experiment Video
Updated: Sep 26, 2025

05:36
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
9.1K
Metastatic Renal Cell Carcinoma With Sarcomatoid Features
Oncology (Williston Park, N.Y.)
|April 18, 2022
Summary
A 38-year-old woman was diagnosed with advanced clear cell renal cell carcinoma (RCC) with sarcomatoid features, presenting with fatigue, weight loss, and flank pain. She received first-line systemic treatment for poor-risk metastatic disease.
Area of Science:
- Oncology
- Nephrology
- Pathology
Background:
- Renal cell carcinoma (RCC) is a significant health concern.
- Metastatic RCC with sarcomatoid features presents a challenging clinical scenario.
- Early and accurate diagnosis is crucial for effective treatment.
Purpose of the Study:
- To present a case of metastatic clear cell renal cell carcinoma (RCC) with sarcomatoid features.
- To highlight the diagnostic process and initial management of advanced RCC.
- To underscore the importance of histopathological analysis in risk stratification.
Main Methods:
- Clinical presentation of a 38-year-old female patient.
- Laboratory investigations including serum calcium and lactate dehydrogenase.
- Diagnostic imaging with CT scan.
- Histopathological analysis of a renal mass biopsy.
Main Results:
- Diagnosis of clear cell renal cell carcinoma (RCC) with 30% sarcomatoid features.
- Identification of a large left renal mass with lung and mediastinal lymph node metastases.
- Classification as International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) poor-risk metastatic RCC.
- Initiation of first-line systemic therapy.
Conclusions:
- Metastatic clear cell renal cell carcinoma (RCC) with sarcomatoid features requires prompt diagnosis and treatment.
- Multimodal diagnostic approaches are essential for staging and risk assessment.
- Systemic therapy is indicated for patients with poor-risk metastatic RCC.
Related Concept Videos
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Rous Sarcoma Virus (RSV) and Cancer
5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.5K

